BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37243996)

  • 1. The combined finding of HPV 16, 18, or 45 and cytologic Atypical Glandular Cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinoma.
    Schiffman M; Mirabello L; Egemen D; Befano B; Xiao Y; Wentzensen N; Raine-Bennett T; Nayar R; Cheung LC; Rositch A; Beaty T; Perkins RB; de Sanjose S; Lorey T; Castle PE; Burk RD
    Gynecol Oncol; 2023 Jul; 174():253-261. PubMed ID: 37243996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California.
    Castle PE; Shaber R; LaMere BJ; Kinney W; Fetterma B; Poitras N; Lorey T; Schiffman M; Dunne A; Ostolaza JM; McKinney S; Burk RD
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):946-53. PubMed ID: 21415357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears.
    Derchain SF; Rabelo-Santos SH; Sarian LO; Zeferino LC; de Oliveira Zambeli ER; do Amaral Westin MC; de Angelo Andrade LA; Syrjänen KJ
    Gynecol Oncol; 2004 Dec; 95(3):618-23. PubMed ID: 15581973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cohort study of cervical screening using partial HPV typing and cytology triage.
    Schiffman M; Hyun N; Raine-Bennett TR; Katki H; Fetterman B; Gage JC; Cheung LC; Befano B; Poitras N; Lorey T; Castle PE; Wentzensen N
    Int J Cancer; 2016 Dec; 139(11):2606-15. PubMed ID: 27509172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical glandular cells and development of cervical cancer: Population-based cohort study.
    Norman I; Yilmaz E; Hjerpe A; Hortlund M; Elfström KM; Dillner J
    Int J Cancer; 2022 Dec; 151(11):2012-2019. PubMed ID: 36029205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C; Sargent A; Kitchener HC; Peto J
    Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervix cytology samples revealed increased methylation of the human markers FAM19A4/miR124-2 up to 8 years before adenocarcinoma.
    Lindroth Y; Pedersen L; Alssamaray J; Berglund T; Sundqvist A; Borgfeldt C; Forslund O
    Acta Obstet Gynecol Scand; 2024 Feb; 103(2):378-386. PubMed ID: 37964497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of High-Risk Human Papillomavirus Testing for Atypical Glandular Cells on Cervical Cytology.
    Komatsu H; Oishi T; Osaku D; Sawada M; Kudoh A; Nonaka M; Chikumi J; Sato S; Harada T
    Acta Cytol; 2018; 62(5-6):405-410. PubMed ID: 29990964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
    [No Abstract]   [Full Text] [Related]  

  • 11. Atypical glandular cells in Pap tests: cytology-histology correlation and risk assessment with human papillopmavirus (HPV) testing.
    Goetz LH; Evans HL; Armylagos D; Zhou H; Mody DR; Schwartz MR; Ge Y
    J Am Soc Cytopathol; 2024; 13(3):227-232. PubMed ID: 38401997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells: a Gynecologic Oncology Group study in United States.
    Liao SY; Rodgers WH; Kauderer J; Bonfiglio TA; Walker JL; Darcy KM; Carter R; Hatae M; Levine L; Spirtos NM; Stanbridge EJ
    Int J Cancer; 2009 Nov; 125(10):2434-40. PubMed ID: 19670419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Human Papillomavirus Non-16/18, Type-Specific Risk for Cervical Intraepithelial Neoplasia Grade 3 or Worse Among Women With Cervical Atypical Glandular Cells.
    Yilmaz E; Lagheden C; Ghaderi M; Wang J; Dillner J; Elfström KM
    Obstet Gynecol; 2023 Sep; 142(3):679-687. PubMed ID: 37535949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
    Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
    BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical glandular cells of undetermined significance. Outcome predictions based on human papillomavirus testing.
    Krane JF; Lee KR; Sun D; Yuan L; Crum CP
    Am J Clin Pathol; 2004 Jan; 121(1):87-92. PubMed ID: 14750245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand.
    Simonella LM; Lewis H; Smith M; Neal H; Bromhead C; Canfell K
    BMC Infect Dis; 2013 Mar; 13():114. PubMed ID: 23452957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of human papillomavirus testing in the management of atypical glandular cells.
    Schnatz PF; Sharpless KE; O'Sullivan DM
    J Low Genit Tract Dis; 2009 Apr; 13(2):94-101. PubMed ID: 19387129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
    Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
    Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
    Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of high-grade cervical disease with human papillomavirus detection in women with glandular and squamous cytologic abnormalities.
    de Oliveira ER; Derchain SF; Sarian LO; Rabelo-Santos SH; Gontijo RC; Yoshida A; Andrade LA; Zeferino LC
    Int J Gynecol Cancer; 2006; 16(3):1055-62. PubMed ID: 16803485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.